Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$cero](/topic/$cero)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cero/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cero/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-04-27  
**1-Year Low**: XX% on 2025-06-01  

**Most Supportive Themes**
- **Positive Sentiment and Engagement:** (60%) $CERO sentiment is up significantly, and engagements are also up, indicating positive momentum.
- **FDA Fast Track Designation:** (20%) CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML).
  
**Most Critical Themes**
- **Mentions Decline:** (10%)  Mentions of $CERO are down significantly over the last month.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XXX      | X% | XXXXXX  | XX% | XX       | X% |
|         |          |    |         |     |          |    |
| Total   | XXX      | X% | XXXXXX  | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cero

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XXX% no change
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-06-01

Most Supportive Themes

  • Positive Sentiment and Engagement: (60%) $CERO sentiment is up significantly, and engagements are also up, indicating positive momentum.
  • FDA Fast Track Designation: (20%) CERo Therapeutics Receives FDA Fast Track Designation for CER-1236 in Acute Myeloid Leukemia (AML).

Most Critical Themes

  • Mentions Decline: (10%) Mentions of $CERO are down significantly over the last month.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX X% XXXXXX XX% XX X%
Total XXX X% XXXXXX XX% XX X%
$cero Sentiment
/topic/$cero/sentiment